ClinicalTrials.Veeva

Menu

Orthorexia Nervosa in Fibromyalgia

B

Beylikduzu State Hospital

Status

Enrolling

Conditions

Fibromyalgia

Treatments

Other: Fibromyalgia

Study type

Observational

Funder types

Other

Identifiers

NCT06947200
BeylikduzuStateH18

Details and patient eligibility

About

This clinical cross-sectional study will include 84 female patients aged between 18 and 65 years who have been diagnosed with fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria. Sociodemographic data will be recorded at the beginning of the study. Pain severity will be assessed using the Visual Analog Scale (VAS). Orthorexia nervosa-related symptoms will be evaluated with the ORTO-11 scale. Body image will be assessed with the Body Appreciation Scale 2, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and fibromyalgia-related impact will be assessed with the Fibromyalgia Impact Questionnaire (FIQ).

Enrollment

84 estimated patients

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female patients aged 18-65 years.
  • Diagnosis of fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria.
  • Willingness to participate and provision of written informed consent.

Exclusion criteria

  • Refusal to participate.
  • Presence of diagnosed psychiatric disorders.
  • Presence of cognitive impairment.
  • Use of medications that may affect mood.

Trial design

84 participants in 1 patient group

fibromyalgia group
Treatment:
Other: Fibromyalgia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems